Insights into the Structural Coexistence of Hexameric States in Microcrystalline Insulin Formulations in the Solid State
- 28 May 2026
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (7) , 3697-3709
Abstract
The structural complexity and insoluble nature of solid-state therapeutic proteins pose major challenges for their pharmaceutical quality control. Many conventional analytical methods cannot be applied directly to fully formulated drug products, leaving important aspects of their higher-order structure (HOS) poorly understood. In this work, we use high-resolution, proton-detected solid-state NMR (ssNMR) spectroscopy under fast magic-angle spinning (MAS) to probe the atomic-level HOS of insulin directly in its native formulated state. Recombinant human insulin powder was compared with three commercial Neutral Protamine Hagedorn (NPH) crystalline suspensions: Humulin 70/30, Insugen 70/30, and NovoMix 30. Two-dimensional (2D) 13C-1H correlation spectra showed that the overall insulin fold is conserved across all samples. In contrast, the 2D 15N-1H spectra provided a much more sensitive fingerprint of HOS and revealed clear structural differences. The amorphous insulin powder exhibits a conformationally heterogeneous ensemble characterized by a complex interplay of static disorder, dynamic averaging, and potential partial unfolding reflecting a nonhexameric, T-like architectural state. In contrast, the formulated suspensions show significantly increased 15N chemical shift dispersion, consistent with more rigid, hexameric assemblies. Inspection of the allosteric reporter residues GlyB8 and ThrA8 shows that the NPH crystals are not locked into a single R6 conformation. Instead, multiple allosteric states are present, plausibly reflecting differences in hydration and phenolic ligand binding within the lattice. The NovoMix 30 formulation (insulin aspart) exhibits further line broadening, consistent with increased lattice disorder introduced by the ProB28 → Asp substitution. These observations illustrate how solid-state NMR can resolve formulation-dependent conformational heterogeneity and provide structural support for biosimilarity evaluation in solid-state protein therapeutics.Keywords
Funding Information
- Indian Institute of Technology Ropar
- University Grants Commission
This publication has 64 references indexed in Scilit:
- Higher Order Structure Differences Among Insulin Crystalline Drugs Revealed by 2D heteronuclear NMRChemMedChem, 2024
- De Novo 3D Structure Determination from Sub‐milligram Protein Samples by Solid‐State 100 kHz MAS NMR SpectroscopyAngewandte Chemie International Edition, 2014
- Assessment of Higher Order Structure Comparability in Therapeutic Proteins Using Nuclear Magnetic Resonance SpectroscopyJournal of Pharmaceutical Sciences, 2013
- SHIFTX2: significantly improved protein chemical shift predictionJournal of Biomolecular NMR, 2011
- Proton‐Detected Solid‐State NMR Spectroscopy of Natural‐Abundance Peptide and Protein PharmaceuticalsAngewandte Chemie, 2009
- Structure of human insulin monomer in water/acetonitrile solutionJournal of Biomolecular NMR, 2007
- Zinc–Ligand Interactions Modulate Assembly and Stability of the Insulin Hexamer – A ReviewBioMetals, 2005
- Insulin Structure and Stability1993
- Structure of a rhombohedral R6 insulin/phenol complexProteins: Structure, Function, and Bioinformatics, 1992
- PROTAMINE INSULINATEJAMA, 1936